CAMBRIDGE, Mass., Aug. 25, 2022 -- Aktis Oncology, a biotechnology company discovering and developing novel classes of targeted alpha radiopharmaceuticals to treat a broad range of solid tumors, today announced...
Jeff Collins will participate in the US-India BioPharma Summit (theme: "Delivering Affordable Innovation through Cross-Border Partnerships") in Cambridge, MA
News | 06. 13. 2008
